Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?
The review contains actual data on possible approaches aimed at improving the prognosis in a special category of patients with extremely high cardiovascular risk, as well as in patients with recent acute coronary syndrome combined with comorbidity, including multifocal atherosclerosis. Currently, th...
Saved in:
| Main Authors: | M. V. Zykov, O. L. Barbarash |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
by: O. L. Barbarash, et al.
Published: (2020-09-01) -
Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01) -
CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2015-11-01) -
THE FACTORS ASSOCIATED WITH PRESCRIPTION OF CARDIOVASCULAR PREVENTIVE TREATMENT IN PATIENTS WITH LOWER EXTREMITIES ATHEROSCLEROSIS
by: A. N. Sumin, et al.
Published: (2016-12-01) -
Exploring Disparities in Atherosclerosis Comorbidity with Aortic Aneurysm
by: Aksana N. Kucher, et al.
Published: (2025-03-01)